Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Afatinib for Erlotinib Refractory Brain Metastases in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer: Can High-Affinity TKI Substitute for High-Dose TKI?

× No keyword cloud information.

5 in total

Review 1. Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.

Authors: Grainne M O'Kane; Natasha B Leighl
Journal: Transl Lung Cancer Res Date: 2016-12

Review 2. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.

Authors: Akimasa Sekine; Hiroaki Satoh
Journal: Med Oncol Date: 2017-05-29 Impact factor: 3.064

3. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.

Authors: Samuel M Shin; Benjamin T Cooper; Abraham Chachoua; James Butler; Bernadine Donahue; Joshua S Silverman; Douglas Kondziolka
Journal: J Neurooncol Date: 2015-10-31 Impact factor: 4.130

Review 4. Systemic Immunotherapy for the Treatment of Brain Metastases.

Authors: Justine V Cohen; Harriet M Kluger
Journal: Front Oncol Date: 2016-03-09 Impact factor: 6.244

5. Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer.

Authors: Po-Lan Su; Yi-Lin Wu; Wei-Yuan Chang; Chung-Liang Ho; Yau-Lin Tseng; Wu-Wei Lai; Wu-Chou Su; Chien-Chung Lin; Szu-Chun Yang
Journal: Ther Adv Med Oncol Date: 2018-09-25 Impact factor: 8.168

5 in total